Mantle cell lymphoma: 2017 update on diagnosis, risk‐stratification, and clinical management von Vose, Julie M.

Volltext

Mantle cell lymphoma: 2015 update on diagnosis, risk‐stratification, and clinical management von Vose, Julie M.

Volltext

Mantle cell lymphoma: 2013 Update on diagnosis, risk‐stratification, and clinical management von Vose, Julie M.

Volltext

Minority Enrollment to Clinical Trials: Road to Increased Access von Vose, Julie

Volltext

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received von Schnipper, Lowell E, Davidson, Nancy E, Wollins, Dana S, Blayney, Douglas W, Dicker, Adam P, Ganz, Patricia A, Hoverman, J Russell, Langdon, Robert, Lyman, Gary H, Meropol, Neal J, Mulvey, Therese, Newcomer, Lee, Peppercorn, Jeffrey, Polite, Blase, Raghavan, Derek, Rossi, Gregory, Saltz, Leonard, Schrag, Deborah, Smith, Thomas J, Yu, Peter P, Hudis, Clifford A, Vose, Julie M, Schilsky, Richard L

Volltext

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management von Vose, Julie M.

Volltext

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymph... von Advani, Ranjana H., Ansell, Stephen M., Lechowicz, Mary J., Beaven, Anne W., Loberiza, Fausto, Carson, Kenneth R., Evens, Andrew M., Foss, Francine, Horwitz, Steven, Pro, Barbara, Pinter‐Brown, Lauren C., Smith, Sonali M., Shustov, Andrei R., Savage, Kerry J., M. Vose, Julie

Volltext

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients von Sibon, David, Nguyen, Dinh-Phong, Schmitz, Norbert, Suzuki, Ritsuro, Feldman, Andrew L, Gressin, Rémy, Lamant, Laurence, Weisenburger, Dennis D, Rosenwald, Andreas, Nakamura, Shigeo, Ziepert, Marita, Maurer, Matthew J, Bast, Martin, Armitage, James O, Vose, Julie M, Tilly, Hervé, Jais, Jean-Philippe, Savage, Kerry J

Volltext

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab von MEYER, Paul N, KAI FU, VOSE, Julie M, LENZ, Georg, STAUDT, Louis M, CHAN, Wing C, WEISENBURGER, Dennis D, GREINER, Timothy C, SMITH, Lynette M, DELABIE, Jan, GASCOYNE, Randy D, OTT, German, ROSENWALD, Andreas, BRAZIEL, Rita M, CAMPO, Elias

Volltext

Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project von FEDERICO, Massimo, RUDIGER, Thomas, WEISENBURGER, Dennis D, ARMITAGE, James O, MOUNIER, Nicholas, VOSE, Julie M, BELLEI, Monica, NATHWANI, Bharat N, LUMINARI, Stefano, COIFFIER, Bertrand, HARRIS, Nancy L, JAFFE, Elaine S, PILERI, Stefano A, SAVAGE, Kerry J

Volltext

Looking Toward a Bright Future: 2020 ASH Virtual Meeting Delivers Promising Data von Vose, Julie M

Volltext

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma von JIA RUAN, MARTIN, Peter, CHADBURN, Amy, CESARMAN, Ethel, COLEMAN, Morton, LEONARD, John P, FURMAN, Richard R, LEE, Shing M, CHEUNG, Ken, VOSE, Julie M, LACASCE, Ann, MORRISON, Julia, ELSTROM, Rebecca, ELY, Scott

Volltext

Use of Real-World Evidence in Hematology/Oncology Treatment Optimization von Vose, Julie M

Volltext

Revised Response Criteria for Malignant Lymphoma von CHESON, Bruce D, PFISTNER, Beate, ROSEN, Steven T, STROOBANTS, Sigrid, LISTER, T. Andrew, HOPPE, Richard T, DREYLING, Martin, TOBINAI, Kensei, VOSE, Julie M, CONNORS, Joseph M, FEDERICO, Massimo, DIEHL, Volker, JUWEID, Malik E, GASCOYNE, Randy D, SPECHT, Lena, HORNING, Sandra J, COIFFIER, Bertrand, FISHER, Richard I, HAGENBEEK, Anton, ZUCCA, Emanuele

Volltext

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy von CHOI, William W. L, WEISENBURGER, Dennis D, VOSE, Julie M, HANS, Christine P, KAI FU, SMITH, Lynette M, MIN LI, ZHONGFENG LIU, GASCOYNE, Randy D, ROSENWALD, Andreas, OTT, German, RIMSZA, Lisa M, GREINER, Timothy C, CAMPO, Elias, JAFFE, Elaine S, JAYE, David L, STAUDT, Louis M, CHAN, Wing C, PIRIS, Miguel A, BANHAM, Alison H, DELABIE, Jan, BRAZIEL, Rita M, HUIMIN GENG, IQBAL, Javeed, LENZ, Georg

Volltext

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transpl... von VOSE, Julie M, CARTER, Shelly, HOROWITZ, Mary, FISHER, Richard, TOMBLYN, Marcie, BURNS, Linda J, AYALA, Ernesto, PRESS, Oliver W, MOSKOWITZ, Craig H, STADTMAUER, Edward A, MINESHI, Shin, AMBINDER, Richard, FENSKE, Timothy

Volltext

Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma von Wiernik, Peter H, Lossos, Izidore S, Tuscano, Joseph M, Justice, Glen, Vose, Julie M, Cole, Craig E, Lam, Wendy, McBride, Kyle, Wride, Kenton, Pietronigro, Dennis, Takeshita, Kenichi, Ervin-Haynes, Annette, Zeldis, Jerome B, Habermann, Thomas M

Volltext

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma von WITZIG, Thomas E, WIERNIK, Peter H, ERVIN-HAYNES, Annette, ZELDIS, Jerome B, VOSE, Julie M, MOORE, Timothy, REEDER, Craig, COLE, Craig, JUSTICE, Glen, KAPLAN, Henry, VORALIA, Michael, PIETRONIGRO, Dennis, TAKESHITA, Kenichi

Volltext

MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications von Bi, Chengfeng, Huang, Yuhua, Ali, Roshia, Wang, Fang, Yang, Xia, Bouska, Alyssa, Xu, Lu, Hao, Xinbao, Lunning, Matthew A, Chan, Wing C, Iqbal, Javeed, Weisenburger, Dennis D, Vose, Julie M, Fu, Kai

Volltext

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study von FRIEDBERG, Jonathan W, TAYLOR, Michael D, ZELENETZ, Andrew D, LINK, Brian K, CERHAN, James R, FLOWERS, Christopher R, DILLON, Hildy, FARBER, Charles M, ROGERS, Eric S, HAINSWORTH, John D, WONG, Elaine K, VOSE, Julie M

Volltext